Table 1.
Clinical characteristics. Asterisks mark significant differences between groups (Mann–Whitney test, * p < 0.05, ** p < 0.01).
| Whole Cohort (n = 116, Median with IQR) |
w/Infection-Triggered Onset (n = 86, Median with IQR) |
w/o Infection-Triggered Onset (n = 30, Median with IQR) |
Inf. vs. Non-Inf. |
|
|---|---|---|---|---|
| Age | 42.5a (31–50) | 39a (31–47) | 49a (40–54) | p: 0.005 ** |
| Disease duration | 4a (2–9) | 3a (1–8) | 6.50a (2.00–14.25) | p: 0.022 * |
| Sex (f/m) | 83/33 (72%/28%) | 64/22 (74%/26%) | 19/11 (63%/37%) | p: 0.247 |
| Fatigue | 8 (7–9) | 8 (7–9) | 8.50 (8–10) | p: 0.113 |
| Cognitive-score | 7 (5.67–8.00) | 7.21 (5.92–8.00) | 6.84 (5.67–7.96) | p: 0.351 |
| Muscle pain | 7 (5–8) | 7 (5–8) | 8 (6.00–8.38) | p: 0.187 |
| Immune-score | 5.33 (4.00–6.67) | 5.66 (4.17–7.00) | 5.17 (3.67–5.96) | p: 0.226 |
| Bell-Score | 30 (30–40) | 30 (30–40) | 30 (30–40) | p: 0.560 |
| Chalder-Fatigue Score | 27 (25–30) | 28 (25.88–30) | 26 (24–30) | p: 0.130 |
| SF-36 Score physical function |
45 (20–55) | 45 (18.75–61.25) | 40 (30–50) | p: 0.834 |
| COMPASS 31 total score |
45.70 (35.18–55.42) | 45.47 (34.36–55.34) | 46.37 (39.28–56.13) | p: 0.687 |
| COMPASS 31 orthostatic score |
28 (20–32) | 28 (20–32) | 28 (20–32) | p: 0.954 |
| COMPASS 31 vasomotoric score |
0 (0–3) | 0 (0–3) | 0 (0–3) | p: 0.646 |
| COMPASS 31 secretomotoric score |
6.42 (3.75–8.56) | 6.42 (2.14–8.56) | 6.42 (4.28–8.56) | p: 0.294 |
| COMPASS 31 gastrointestinal score |
8.90 (6.90–12.46) | 8.90 (6.23–12.46) | 8.90 (7.12–12.02) | p: 0.932 |
| COMPASS 31 bladder score |
1.10 (0–2.20) | 1.10 (0–2.20) | 0 (0–2.20) | p: 0.369 |
| COMPASS 31 pupillomotoric score |
2.40 (1.43–3.00) | 2.40 (1.50–3.00) | 2.40 (1.20–3.00) | p: 0.772 |